Results 1 to 10 of about 293,347 (149)
Can We Improve Antifungal Susceptibility Testing? [PDF]
Frontiers in Cellular and Infection Microbiology, 2021 Systemic antifungal agents are increasingly used for prevention or treatment of invasive fungal infections, whose prognosis remains poor. At the same time, emergence of resistant or even multi-resistant strains is of concern as the antifungal arsenal is ...
Charlotte Durand +8 more
doaj +3 more sources
Antifungal Susceptibility Testing: A Primer for Clinicians. [PDF]
Open Forum Infectious Diseases, 2021 Clinicians treating patients with fungal infections may turn to susceptibility testing to obtain information regarding the activity of different antifungals against a specific fungus that has been cultured.
Nathan Paul Wiederhold
exaly +3 more sources
Antifungal Susceptibility Testing: Current Approaches. [PDF]
Clinical Microbiology Reviews, 2020 Although not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories.
Shawn R Lockhart, Elizabeth L Berkow
exaly +3 more sources
A Practical Guide to Antifungal Susceptibility Testing. [PDF]
J Pediatric Infect Dis Soc, 2023 We review antifungal susceptibility testing and the development of clinical breakpoints, and detail an approach to using antifungal susceptibility results when breakpoints have not been defined.
Otto WR, Arendrup MC, Fisher BT.
europepmc +2 more sources
Clinical utility of antifungal susceptibility testing. [PDF]
JAC Antimicrob Resist, 2022 Invasive fungal diseases cause significant morbidity and mortality, in particular affecting immunocompromised patients. Resistant organisms are of increasing importance, yet there are many notable differences in the ability to both perform and interpret ...
McCarty TP +3 more
europepmc +2 more sources
Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance. [PDF]
J Fungi (Basel), 2022 Susceptibility testing can yield variable results because it is method (commercial or reference), agent, and species dependent. Therefore, in order for results to be clinically relevant, MICs (minimal inhibitory concentrations) or MECs (minimal effective
Espinel-Ingroff A.
europepmc +2 more sources
Antifungal Susceptibility Testing Experience in the Management of Culture-Positive Mucormycosis: Observation from a Large Healthcare System [PDF]
Journal of FungiBackground: Mucormycosis, an invasive fungal infection with high morbidity and mortality rates, requires prompt surgical and antifungal therapies; however, the role of antifungal susceptibility testing (AFST) in clinical management of mucormycosis ...
Maryam Naveed +4 more
doaj +2 more sources
BMC Research Notes, 2017 Background Candida species are responsible for various clinical infections ranging from mucocutaneous infection to life threatening invasive diseases along with increased resistance to antifungal drugs has made a serious concern. Resistance to antifungal
Sundar Khadka +12 more
doaj +2 more sources
Susceptibility Testing of Fungi to Antifungal Drugs
Journal of Fungi, 2018 Susceptibility testing of fungi against antifungal drugs commonly used for therapy is a key component of the care of patients with invasive fungal infections.
Maurizio Sanguinetti, Brunella Posteraro
doaj +2 more sources
Antifungal Susceptibility Testing of Fusarium: A Practical Approach
Journal of Fungi, 2017 In vitro susceptibility testing of Fusarium is becoming increasingly important because of frequency and diversity of infections and because resistance profiles are species-specific. Reference methods for antifungal susceptibility testing (AFST) are those
Abdullah M. S. Al-Hatmi +4 more
doaj +2 more sources